Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Retained Earnings (2016 - 2026)

Avanos Medical's Retained Earnings history spans 13 years, with the latest figure at -$779.9 million for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 10.31% to -$779.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$779.9 million, a 10.31% decrease, with the full-year FY2025 number at -$779.9 million, down 10.31% from a year prior.
  • Retained Earnings hit -$779.9 million in Q4 2025 for Avanos Medical, roughly flat from -$778.6 million in the prior quarter.
  • Over the last five years, Retained Earnings for AVNS hit a ceiling of -$30.0 million in Q2 2021 and a floor of -$779.9 million in Q4 2025.
  • Historically, Retained Earnings has averaged -$276.5 million across 5 years, with a median of -$301.4 million in 2022.
  • The widest YoY moves for Retained Earnings: up 90.06% in 2022, down 877.0% in 2022.
  • Tracing AVNS's Retained Earnings over 5 years: stood at -$33.8 million in 2021, then plummeted by 648.82% to -$253.1 million in 2022, then dropped by 24.42% to -$314.9 million in 2023, then tumbled by 124.52% to -$707.0 million in 2024, then dropped by 10.31% to -$779.9 million in 2025.
  • Business Quant data shows Retained Earnings for AVNS at -$779.9 million in Q4 2025, -$778.6 million in Q3 2025, and -$32.0 million in Q2 2025.